Unusual domain architecture of aminoacyl tRNA synthetases and their paralogs from Leishmania major by Gowri, V. S. et al.
Gowri et al. BMC Genomics 2012, 13:621
http://www.biomedcentral.com/1471-2164/13/621RESEARCH ARTICLE Open AccessUnusual domain architecture of aminoacyl tRNA
synthetases and their paralogs from Leishmania
major
V S Gowri1,2, Indira Ghosh2, Amit Sharma3 and Rentala Madhubala1*Abstract
Background: Leishmania major, a protozoan parasite, is the causative agent of cutaneous leishmaniasis. Due to the
development of resistance against the currently available anti-leishmanial drugs, there is a growing need for specific
inhibitors and novel drug targets. In this regards, aminoacyl tRNA synthetases, the linchpins of protein synthesis,
have received recent attention among the kinetoplastid research community. This is the first comprehensive survey
of the aminoacyl tRNA synthetases, their paralogs and other associated proteins from L. major.
Results: A total of 26 aminoacyl tRNA synthetases were identified using various computational and bioinformatics
tools. Phylogenetic analysis and domain architectures of the L. major aminoacyl tRNA synthetases suggest a
probable archaeal/eukaryotic origin. Presence of additional domains or N- or C-terminal extensions in 11 aminoacyl
tRNA synthetases from L. major suggests possibilities such as additional tRNA binding or oligomerization or editing
activity. Five freestanding editing domains were identified in L. major. Domain assignment revealed a novel
asparagine tRNA synthetase paralog, asparagine synthetase A which has been so far reported from prokaryotes and
archaea.
Conclusions: A comprehensive bioinformatic analysis revealed 26 aminoacyl tRNA synthetases and five
freestanding editing domains in L. major. Identification of two EMAP (endothelial monocyte-activating polypeptide)
II-like proteins similar to human EMAP II-like proteins suggests their participation in multisynthetase complex
formation. While the phylogeny of tRNA synthetases suggests a probable archaeal/eukaryotic origin, phylogeny of
asparagine synthetase A strongly suggests a bacterial origin. The unique features identified in this work provide
rationale for designing inhibitors against parasite aminoacyl tRNA synthetases and their paralogs.
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Aminoacyl tRNA synthetases (aaRSs) are indispensable
components of protein synthesis. They covalently append
amino acids to their cognate tRNA. Most organisms pos-
sess separate tRNA synthetases for each of the 20 standard
amino acids. There are two classes of aminoacyl tRNA
synthetases each comprising of ~10 tRNA synthetase
enzymes - Class I tRNA synthetases contain the classical
Rossmann-nucleotide binding catalytic domain with two
highly conserved 'HIGH' and 'KMSKS' catalytic motifs
which are critical for their function [1]. Class II enzymes* Correspondence: madhubala@mail.jnu.ac.in
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Despite these structural and sequence differences, both
tRNA synthetases catalyse the same two step reaction.
The first step involves activation of the amino acid by
ATP to form aminoacyl adenylate. The second step is
the attachment of the aminoacyl group to the cognate
tRNA. While Class I attaches aminoacyl group to the
2'-hydroxyl group of tRNA, Class II synthetases attach
them to 3'-hydroxylgroup of tRNA. The 3-D structure
and the specific anticodon in the tRNA determine the
specificity of tRNA synthetases. Most eukaryotes carry
two genes for each of the 20 standard aminoacyl tRNA
synthetases (cytosolic and mitochondrial). However, try-
panosomatids carry only a single copy per aminoacid
except for Asp, Trp and Lys [2,3].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tRNA synthetase showed a complete arrest of growth in
the bloodstream forms of the parasite suggesting an es-
sential role in cell survival [4]. Mammalian methionyl
tRNA synthetase provides a cytosolic anchoring site for
Aminoacyl tRNA synthetase Interaction Multifunctional
Protein-3 (AIMP-3/p18), a potent tumor suppressor in
addition to its essential role in initiating translation [5].
Participation of aminoacyl tRNA synthetases in cell apop-
tosis, rRNA synthesis, RNA trafficking, multisynthetase
enzyme complex formation supplement their essential
role in protein synthesis [6,7]. As an inevitable compo-
nent of protein synthesis, aminoacyl tRNA synthetases
have been important antibacterial drug targets. An im-
portant example of aaRS inhibitor is provided by the
antibiotic mupirocin which selectively inactivates bacter-
ial Isoleucyl-tRNA synthetase (IleRS) [8,9]. Four distinct
aminoacyl tRNA synthetases in Anabaena sp. PCC 7120
contain a novel CAAD domain that bears putative trans-
membrane helices. Domain deletion studies indicate its
essential role in membrane anchoring and a purely struc-
tural role and do not alter the catalytic properties of the
enzyme [10]. Eukaryotic tRNA synthetases, unlike their
prokaryotic counterparts carry additional domains or
extensions in their N- or C-terminal regions which
mediate protein-protein interaction or involved in tRNA
binding. A comprehensive computational analysis of the
aminoacyl tRNA synthetases of Plasmodium falciparum
reveals novel domain architectures. Phylogenetic analyses
of several Pf aaRSs reconcile their evolutionary link to
plants and bacteria [11]. Recently, the expression and
localization profiles of the cis- and trans- aaRS editing
domains of P. falciparum showed an uneven distribution
of 8 aaRS editing domains in the different cellular com-
partments [12].
Leishmaniasis is one of the deadly diseases caused by
the different species of Leishmania. Increasing resistance
to presently available anti-leishmanial drugs poses a need
for identification of novel drug targets as well as specific
inhibitors for treating leishmaniasis. In this regard, ami-
noacyl tRNA synthetases, the versatile players of protein
translation machinery have received attention in kineto-
plastid research community [13]. Very recently, crystal
structure of a methionyl-tRNA synthetase [14] and a novel
pseudodimeric structure of a tyrosyl tRNA synthetase
from Leishmania major have been solved [15]. Substantial
differences between the human tRNA synthetases and the
L. major tRNA synthetase homologue promise a rationale
for designing inhibitors to selectively target the parasite
enzyme. A comprehensive bioinformatic analysis employ-
ing the profile-based hidden markov model (HMM) has
identified aaRSs and aaRS related proteins from L. major.
The sequence features and novel domain architectures of
aaRSs from L. major were analyzed using a combinationof BLAST and HMM search tools. Domain assignment
revealed a novel asparagine tRNA synthetase (AsnRS)
paralog Asparagine synthetase A (AsnA) which has been
so far reported from prokaryotes and archaea and has
been shown to be absent in eukaryotes. We for the first
time report the phylogeny and structural analysis of a
eukaryotic AsnA from L. major.
Results and discussions
A total of 26 aminoacyl tRNA synthetases (11 Class I; 14
Class II; 1 non-standard) were identified in L. major
(Table 1) using Hidden Markov Models (HMMs). Like
other trypanosomatids [2,3], L. major also has a single
copy of the tRNA synthetases except for Asp, Lys, Trp
as well as Pro. The presence of the synthetase and anti-
codon binding domains were confirmed using the Con-
served Domains Database (CDD) domain assignments
from NCBI. Based on the generic domain architecture,
25 L. major sequences identified using the HMM searches
could be certified as authentic aaRSs (Table 1). Among
the tRNA synthetase related proteins, LmjF.16.1130 and
LmjF.22.0470 contain only an RNA binding domain/
Myf domain. However, BLAST sequence search against
PDB database identified human EMAP II-like sequences
(E-value: 2e-21; 37%) as the top hit suggesting their se-
quence relationship with the EMAP II-like sequences such
as P43 from human, Arc1p from yeast, Trbp111 from
A. aeolicus etc. Both LmjF.16.1130 and LmjF.22.0470
also contain a modified heptapeptide motif that has been
shown to be essential for the cytokine activity in the
human EMAP II-like protein [16]. The presence of ‘ELR’
motif at the N-terminus has also been shown to be potent
promoters of angiogenesis [16]. Aminoacyl tRNA synthe-
tase sequences of Cys (LmjF.12.0250), Asn (LmjF.34.2340),
Lys (LmjF.15.0230) and Tyr (LmjF.14.1370) [15] possess
an “ELR” motif at the N-terminus. LmjF.26.0830 contains
only the Class II synthetase catalytic core with all the
three active site motifs conserved. BLAST search against
PDB database identified the E. coli Asparagine synthetase
A structure as the single hit with a reliable statistical
value (E-value: 8e-111). LmjF.26.0830 shares 58% se-
quence identity with the E. coli Asparagine synthetase A.
As the key players in protein translation, most organ-
isms require 20 standard aminoacyl tRNA synthetases for
protein synthesis. However, indirect routes of GlntRNAGln
and AsntRNAAsn synthesis also exist in many organ-
isms which either completely lack the respective tRNA
synthetases or lack them in some specific organelles such
as mitochondria [17]. Kinetplastid (Trypanosoma and
Leishmania) Seryl tRNA synthetases (SerRS) show a
close functional and evolutionary relationship to the
metazoan SerRS which is supported by the presence of
a metazoan-trypanosomatid specific sequence insertion
in SerRS [18]. The kinetoplastid SerRS also show high
Table 1 List of all the aminoacyl tRNA synthetases and their associated proteins, aaRS paralogs and editing domains with their CDD domain assignments and
subcellular localization
Gene name Length
(aa)
HMM based function
assignment
E-value# Swissprot function
assignment
Subcellular
location
(PSORT II)
CDD based domain assignment
CLASS I aaRS LmjF.12.0250 784 Cysteinyl-tRNA synthetase 1.00E-191 Cysteinyl-tRNA
synthetase
Cytosol CysRS_Core; anticodon_la_like_superfamily
LmjF.15.1440 570 Glutaminyl-tRNA synthetase 8.70E-208 Glutaminyl-tRNA
synthetase
Cytosol GlnRS_core; GlnRS_core; tRNA_synt_Ic_C_superfamily
LmjF.30.3240 594 Glutaminyl-tRNA synthetase 7.00E-079 Glutaminyl-tRNA
synthetase
Cytosol GlnRS_core; GlnRS_core; tRNA_synt_Ic_C_superfamily
LmjF.27.1310 692 Arginyl-tRNA synthetase 2.00E-151 Arginyl-tRNA synthetase Cytosol Arg_tRNA_synt_N; ArgRS_Core; anticodon_Ia_like_superfamily
LmjF.36.5620 1009 Isoleucyl-tRNA synthetase 0 Isoleucyl-tRNA synthetase Cytosol IleRS_Core; Anticodon_Ia_like_superfamily
LmjF.13.1100 1075 Leucyl-tRNA synthetase 3.70E-140 Leucyl-tRNA synthetase Cytosol IleRS_Core; Anticodon_Ia_like_superfamily
LmjF.21.0810* 747 Methionyl-tRNA synthetase 6.00E-145 Methionyl-tRNA
synthetase
Cytosol MetRS_Core_superfamily; Anticodon_Ia_Met
LmjF.23.0300 412 Tryptophanyl-tRNA synthetase 1.90E-062 Tryptophanyl-tRNA
synthetase
Cytosol TrpRS_core
LmjF.29.0060 480 Tryptophanyl-tRNA synthetase 1.70E-095 Tryptophanyl-tRNA
synthetase
Mitochondrial TrpRS_core
LmjF.14.1370* 682 Tyrosyl-tRNA synthetase 1.10E-051 Tyrosyl-tRNA synthetase Endoplasmic
reticulum
TyrRS_core; TyrRS_core
LmjF.30.3130 967 Valyl-tRNA synthetase 0 Valyl-tRNA synthetase Cytosol ValRS_core; anticodon_Ia_Val; Val_tRNA_synt_C_superfamily
CLASS II aaRS LmjF.22.1540 962 Alanyl-tRNA synthetase 3.10E-262 Alanyl-tRNA synthetase Cytosol AlaRS_core; tRNA_SAD
LmjF.30.0460 550 Aspartyl-tRNA synthetase 3.90E-106 Aspartyl-tRNA synthetase Cytosol AspRS_cyto_N; AsxRS_Core
LmjF.21.0895 641 Aspartyl-tRNA synthetase 5.70E-097 Aspartyl-tRNA synthetase Mitochondrial AspRS_cyto_N; ClassII_aaRS_like_core_superfamily;
ClassII_aaRS_like_core_superfamily
LmjF.34.2340 890 Asparaginyl-tRNA synthetase 2.40E-144 Asparaginyl-tRNA
synthetase
Cytosol tRNA_synt_Ic_R1_superfamily; AsnRS_cyto_like_N; AsxRS_core
LmjF.36.3840 628 Glycyl-tRNA synthetase 5.10E-056 Glycyl-tRNA synthetase Cytosol GlyRS_core; HGTP_anticodon
LmjF.30.0130 586 Lysyl-tRNA synthetase 8.20E-184 Lysyl-tRNA synthetase Cytosol LysRS_N; LysRS_Core
LmjF.15.0230 536 Lysyl-tRNA synthetase 9.30E-148 Lysyl-tRNA synthetase Cytosol LysRS_N; LysRS_Core
LmjF.19.1040 633 Phenylalanyl-tRNA synthetase 3.20E-053 Phenylalanyl-tRNA
synthetase
Cytosol B3_4_superfamily; B5_superfamily; PheRS_beta_core
LmjF.32.0870 499 Phenylalanyl-tRNA synthetase 5.90E-052 Phenylalanyl-tRNA
synthetase
Cytosol PheRS_alpha_core
LmjF.18.1210 731 Prolyl-tRNA synthetase 1.30E-188 Prolyl-tRNA synthetase Cytosol Ybak_like_superfamily; ProRS_arch_euk;
HGTP_anticodon_superfamily
LmjF.18.1220 731 Prolyl-tRNA synthetase 1.20E-190 Prolyl-tRNA synthetase Cytosol Ybak_like_superfamily; ProRS_arch_euk;
HGTP_anticodon_superfamily
LmjF.11.0100 474 Seryl-tRNA synthetase 4.40E-135 Seryl-tRNA synthetase Cytosol Seryl_tRNA_N_superfamily; SerRS_Core
LmjF.30.0630 473 Histidyl-tRNA synthetase 2.30E-103 Histidyl-tRNA synthetase Cytosol HisRS_Core; HisRS_anticodon
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Table 1 List of all the aminoacyl tRNA synthetases and their associated proteins, aaRS paralogs and editing domains with their CDD domain assignments and
subcellular localization (Continued)
LmjF.35.1410 787 Threonyl-tRNA synthetase 3.20E-252 Threonyl-tRNA synthetase Cytosol TGS_superfamily; tRNA_SAD; ThrRS_Core; HGTP_anticodon
Non-canonical LmjF.09.0950 595 O-Phosphoseryl-tRNA Selenium
transferase
9.10E-127 SLA/LP autoantigen-like
protein
Nuclear Selenium_SpcS
aaRS associated
proteins
LmjF.22.0470 426 EMAP-II like 1.20E-023 Hypothetical, Conserved Extracellular tRNA_binding_domain_superfamily
LmjF.16.1130 180 EMAP-II like 1.20E-015 Tyrosyl/methionyl-tRNA
synthetase
Cytosol tRNAbindingdomain_superfamily
AsnRS paralog LmjF.26.0830 353 Asparagine Synthetase A 2.00E-002 Aspartate, ammonia
ligase
Mitochondrial ClassII_aaRS_like_core_superfamily
Trans Editing
domains
LmjF.15.0690 491 AlaX 3.90E-028 Hypothetical, conserved Cytosol tRNA_SAD_superfamily
LmjF.03.0710 253 YbaK 2.20E-002 Hypothetical, conserved Cytosol Ybak_like_superfamily
LmjF.21.0910 275 YbaK 7.20E-003 Hypothetical, conserved Cytosol Ybak_like_superfamily
LmjF.36.2730 152 Dtda 1.00E-026 D-tyrosine deacylase Cytosol Dtyr_deacylase
LmjF.34.3360* 211 Dtda 5.40E-020 Hypothetical, conserved Cytosol Dtyr_deacylase_superfamily
* indicates L. major sequences whose crystal structures are available # E-value (Expectation value) is an indication of the significance of a hit to the HMM Model queried. This gives a more quantitative measure of
statistical significance. The lower the E-value, the better is the significance of the hit to the query HMM.
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http://www.biomedcentral.com/1471-2164/13/621affinity for tRNASec [18]. Proteins containing non-standard
aminoacids such as Sec (Selenocysteine) have been
reported from trypanosomatids [19]. The presence of
Selenocysteine incorporation is further supported by the
presence of a selenophosphosynthetase (LmjF.36.5410),
the first enzyme in the selenocysteine tRNA synthesis
as well as a selenocysteine specific elongation factor
(LmjF.34.2840). LmjF.09.0950, a o-phosphoseryl tRNA
(sec) selenium transferase, the third enzyme in the
SectRNASec synthesis with SepSecS-like domains was
also identified using the Hidden Markov Model searches.
Comparison of the number of aminoacyl tRNA synthe-
tases (20 standard aminoacids) of the human with L.
major (Figure 1) shows a disparity in the number of aaRS
for all the aminoacids except for Gly, Glu and Gln where
a single copy is present in both human and Leishmania.
Two copies one each for cytoplasm and mitochondria
of AspRS and TrpRS are present in both human and
L. major. While human possess a single copy of LysRS
and ProRS, L. major has two copies of these predicted to
be in the cytoplasm. One of the LysRS (LmjF.15.0230)
has an “ELR” motif at the N-terminus. The two copies of
ProRS from L. major are identical copies probably a
product of gene duplication. Humans possess the max-
imum number of alanyl and threonyl tRNA synthetases
(3 copies each) compared to L. major which has a singleFigure 1 A panel bar diagram showing the number of the
standard aaRSs in L. major and human.copy of each of them. Non-canonical roles of tRNA
synthetases require their presence in diverse cellular com-
partments. Hence, prediction of subcellular localization
of the LmaaRSs was done using PSORT-II. 80% of the
tRNA synthetases are cytosolic and 10% of them are
present in mitochondria according to PSORT II predic-
tions (Table 1). Nuclear localization was predicted for the
non-standard o-phosphoseryl tRNA(sec) selenium trans-
ferase (LmjF.09.0950). Mitochondrial localization was pre-
dicted for 3 proteins corresponding to an AspRS, AsnA
(AsnRS paralog) and TrpRS (Table 1). Many proteins
that are imported into mitochondrion have targeting
signals typically at the N-terminus [20] or C-terminus or
protein internal. However, numerous mitochondrial pro-
teins have been shown to be lacking these signals includ-
ing those proteins that have been shown to be imported
into mitochondria in trypanosomes. Examples include
the glutamyl and glutaminyl tRNA synthetases from
L. tarentolae [21] and T. brucei [22]. Although, the gluta-
minyl tRNA synthetases are shown to be absent in their
mitochondria, the glutaminyl tRNA synthetase activity
has been shown experimentally in both these organisms.
Hence, it is possible that the single copy tRNA synthe-
tases are probably transported to mitochondria during
translation although PSORT II is unable to predict the
possibility of mitochondrial localization for the single
copy ones. Trans splicing of a leader sequence to the 5’
end of the mRNA is a common phenomenon among
human and protozoa. This results in alternative splicing
in these organisms resulting in proteins with different
properties such as gain or loss of targeting signals. Such a
mapping of the 5’ splice sites using the splice leader trap-
ping method in T. brucei resulted in the discovery of
nearly 2500 alternative splice events in a stage-regulated
manner [23]. The splice sites data for L. major at the tri-
trypdb server suggests an alternate start site as a result of
trans splicing in the promastigote stages for several tRNA
synthetases including the single copy tRNA synthetases
such as the valyl, isoleucyl, leucyl, glutamyl tRNA synthe-
tases [Additional file 1: Table S1].
The tRNA synthetases and other associated proteins
such as the EMAP II and the editing domains although
present in all the trypanosomatids, show interesting
differences between the Leishmania and Trypanosoma
[Additional file 2: Table S2]. There are two AspRS in all
the Leishmania Spp, T. brucei brucei and T. brucei gam-
biense. However, T. congolense and T. vivax have only a
single copy of AspRS. Furthermore, all the Leishmania
spp and Trypanosoma spp carry a single HisRS except
T. congolense. T. cruzi Non-Esmeraldo strain and T.
congolense carry three TrpRS whereas all other trypanos-
tomatids carry two TrpRS. T. cruzi Non-Esmeraldo strain
lacks a MetRS and GlnRS. Moreover, T. cruzi Non-
Esmeraldo strain contains only an alpha chain of PheRS
Gowri et al. BMC Genomics 2012, 13:621 Page 6 of 15
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Although several tRNA synthetases are syntenic and con-
served in Leishmania, the protein expression is regulated
at different stages in different Leishmania species. For
example, SerRS (LmjF.11.0100), LysRS (LmjF.15.230),
glutamyl (LmjF.30.3240), AsnRS (LmjF.34.2340), GlyRS
(LmjF.36.3840), IleRS (LmjF.36.5620) are regulated pre-
dominantly in the promastigotes in L. major [24].
Domain architecture of tRNA synthetases from L. major
All the standard aminoacyl tRNA synthetases contain the
synthetase core domain as well as the anticodon binding
domain in some order. Hence, the presence of these gen-
eric domains helps in distinguishing the aminoacyl tRNA
synthetases from the aminoacyl tRNA synthetase asso-
ciated proteins (aaRS associated proteins) which refers to
EMAP II-like proteins containing only the RNA binding
domains. In addition to these genericdomains, some of
the aminoacyl tRNA synthetases also possess additional
domains or extensions tethered to either N- or C-
terminus which might be involved in RNA binding or
oligomerization. Presence of editing domains ensures the
fidelity of protein translation in some tRNA synthetasesFigure 2 Domain architecture of (a) Class I and (b) Class II LmaaRSs, a
type for domain boundaries correspond to the domain prediction procedu
based HMM predictions). The beginning of ELR motif is denoted by the res
denoted by an underlined residue number. The grey boxes corresponds toby hydrolysing the tRNA aminoacylated with non-cognate
amino acid [25]. Thus, in addition to the aaRS, the editing
domains (both cis- and trans-) are also novel drug targets.
The domain architecture of all the aaRSs (including the
non-standard o-phosphoseryl tRNA(sec) selenium trans-
ferase) with all the additional domains or motifs, trans
editing domains, aaRS paralogs and other aaRS associated
proteins of L. major is shown in Figure 2a and b.
Alanyl and threonyl tRNA synthetases often possess a
secondary associated domain (tRNA_SAD) containing a
HxxxH motif which is typical of a metal dependent hydro-
lases [26]. Alanyl (LmjF.22.1540) and threonyl tRNA
synthetases (LmjF.35.1410) of L. major contain this do-
main. The presence of a tRNA_SAD domain with a con-
served HxxxH motif suggests a functionally important
hydrolytic activity (Figure 2b). LmThrRS also contains a
TGS domain tethered N-terminus to the tRNA_SAD
(Figure 2b). Based on its occurrence in other regulatory
proteins, this domain is proposed to bind ligands (most
likely nucleotides) [27]. Hence, the TGS domain in
LmThrRS probably has a regulatory role. In addition to an
editing domain tRNA_SAD, LmAlaRS has a C-terminal
extension (DHHA1 domain). Crystal structure andaRS associated proteins, and trans editing domains. The box line
re (solid line for PFAM HMM predictions; dotted line for SUPERFAMILY
idue number in red color font. The beginning of heptapeptide motif is
lower prediction accuracy (E:value: greater than 1E-05).
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AlaRS shows that it promotes cooperative binding of the
aminoacylation and editing domain to tRNAAla [28].
While the C-terminal extension of LmAlaRS might be
involved in oligomerization, N- or C-terminal extensions
of SerRS, LeuRS and LysRS have been shown to provide
additional tRNA binding to these synthetases [29-31].
The N-terminal extension of LmLeuRS (LmjF.13.1100) is
present as insertion in the editing domain denoted as
CP1 (Connective Polypeptide) (Figure 2a). Only three
LeuRS editing domains have been structurally charac-
terized till date [31,32]. The CP1 of E. coli LeuRS lacks
this insertion and hence lacks the editing activity as an
isolated CP1 domain [33]. Recent crystallographic and
biochemical evidences reconcile this observation [31].
LmLeuRS has an N-terminal extension of approximately
35 residues long. Secondary structure prediction of this
insertion using PSIPRED server [29] suggests that this
N-terminal extension has a helix of ~15 residues long
(Additional file 3: Figure S1). Further, sequence compari-
son of the editing domain of LmleuRS with that of
human, E. coli, A. aeolicus and G. lamblia suggest the
T-rich region, GTG motif and the conserved Asp essential
for function are all conserved. Sequence-based phylogeny
suggests a close evolutionary relationship of LmLeuRSCP1
to GlLeuRSCP1 which has been verified to possess fully
functional editing domain in isolation [31]. The anti-
fungal drug (AN2690) binding residues of C. albicans
LeuRS are also highly conserved in LmLeuRS editing
domain. Although LmLeuRS is ~1100 residues long, the
presence of a probable functional editing domain in iso-
lation proves it to be a novel drug target and encourages
experimental verification for its drug binding abilities.
L. major encodes two cytosolic LysRS (LmjF.15.0230
and LmjF.30.0130) (Table 1). One of the LmLysRS
(LmjF.15.0230) has an N-terminal extension (DUF972) sim-
ilar to the mammalian LysRS (Figure 2b). The N-terminal
extension of mammalian LysRS has been shown to par-
ticipate in non-specific tRNA binding [26]. Deletion of
this N-terminal extension has been shown to reduce the
tRNA binding affinity by 100-fold and hence decreases
the aminoacylation of tRNAlys by 3-fold in mammals
[29]. Based on the sequence homology of the LmLysRS
(LmjF.15.0230) to the mammalian LysRS, the N-terminal
extension in LmjF.15.0230 can be expected to participate
in a non-specific tRNA binding and could probably play a
role in amino acylation activity of this LysRS. LmjF.15.0230
also contains an ‘ELR’ motif at the N-terminal extension.
However, chemokine activity of this ‘ELR’ motif in
LmLysRS requires experimental verification.
Stand-alone deacylase/trans editing domains in L. major
While the pairing of the correct amino acid to their cog-
nate tRNA is done by the aminoacyl tRNA synthetases,faithful translation in protein synthesis is ensured by the
presence of editing domains(ED) either tethered to the
aaRS (cis editing domains) or as free standing editing
domains (trans editing domains). There are 8 cis editing
domains tethered to AlaRS, ThrRS, PheRS, LeuRS, IleRS,
ValRS, ProRS (both the copies) and 5 trans editing
domains which includes the AlaX (AlaRS ED), two
YbaK-like (ProRS ED) and two D-tyrosyl deacylases
(DTDAs) in L. major.
The Second Associated domain (tRNA_SAD) of
AlaRS/ThrRS are generally tethered to the synthetase
core. In L. major, in addition to the tethered editing
domains in the AlaRS (LmjF.22.1540) and ThrRS
(LmjF.35.1410), a freestanding tRNA_SAD (LmjF.15.0690)
domain (Figure 2a) was also found. There are two types
of standalone AlaX domains: AlaX-M, AlaX-S. Both the
domains differ in their metal coordination types (Zn co-
ordination). In AlaX-M, in addition to coordination with
the Cysteine residues, there is coordination with a water
molecule. However, in AlaX-S, the metal ion is coordi-
nated only by cysteines [34,35]. The standalone domain
has all the four cysteines conserved. Sequence based
phylogeny suggests that L. major tRNA_SAD standalone
domain is closer to AlaX-M family (Additional file 4:
Figure S2).
In addition to the tethered Ybak/ProX deacylase
domains in the two LmProRS copies, two freestanding
YbaK domains (LmjF.03.0710 and LmjF.21.0910) are
also found (Figure 2a). Sequence based phylogeny of
both tethered and standalone deacylase domains in L.
major with the available crystal structures of YbaK/
ProX domains suggest that the tethered deacylase
domains are closer in terms of their amino acid sequence
to ProX type which specifically deacylate the misacylated
tRNAPro with Alanine [36,37] while the trans deacylase
domains are closer to YbaK-like which deacylate the
misacylated tRNAPro with Cysteine [37,38] (Additional
file 5: Figure S3). The trans editing domain LmjF.03.0710
lacks the active site lysine which is shown to be critical
in H. influenza YbaK domain by mutagenesis (K46 in
PDB: 1DBX) [38-40]. Thus, only one of the trans editing
domain of LmProRS (LmjF.21.0910) which has the active
site lysine conserved might be functional.
Detection of D-amino acids in the form of free amino-
acids, peptides and proteins in various living organisms
from bacteria to human challenges the current concept
of protein synthesis [41,42]. D-Tyr tRNATyr deacylases
(DTDA), a new class of tRNA dependent hydrolases
provide a novel checkpoint by recycling the misaminoa-
cylated D-Tyr tRNATyr. There are two DTDAs in L. major.
One of the LmDTDA2 (LmjF.34.3360) has a crystal struc-
ture solved using the Structural Genomics of Pathogenic
Protozoa Consortium (SGPP) (PDB: 1TC5). This sequence
is closer to the human, mouse DTDA2 homologue. The
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the PfDTDA homologue (Additional file 6: Figure S4)
whose structure has been solved recently (3KO5). Like
other deacylases/editing domains of aaRSs, DTDA has
been shown to be a novel drug target in P. falciparum
[43]. While structural comparison of the LmDTDA2 and
PfDTDA1 shows major differences in the length of a
specific loop, 3-D structural modeling of LmDTDA1
homologue (LmjF.36.2730) based on the PfDTD tem-
plate structure and a comparative structural analysis of
LmDTDA1 with a perspective of inhibitor design is
commendable.
Novel aminoacyl tRNA synthetases from L. major
L. major, like other trypanosomatids encodes two AspRS
enzymes (one cytosolic and a mitochondrial enzyme).
Conserved Domains Database (CDD) based domain archi-
tecture suggest that the cytosolic AspRS (LmjF.30.0460)
has a non-discriminating catalytic core (AsxRS which
can charge Asp/Asn) while the mitochondrial copy
(LmjF.21.0895) contains the canonical AspRS catalytic
core (Table 1). Sequence-based phylogeny clearly sug-
gests that Leishmania major encodes two Eukaryotic or
Archaeal type AspRS (Non-discriminating) (Figure 3).
This is further confirmed by the PFAM domain assign-
ments. While the Bacterial AspRS contain a GAD
domain inserted within the catalytic core which could
probably function as an editing domain, the Archaeal/
Eukaryotic AspRS lack this GAD domain and hence
belong to the non-discriminating type AspRS. An Asp/
Asn synthetase domain (AsxRS) can acylate either Asp or
Asn in a non-discriminating manner [44,45]. Generally, a
non-discriminating type AspRS is involved in the indirect
pathway of Asparagine tRNA synthesis [44,45]. TheFigure 3 Sequence based phylogeny of aspartyl tRNA synthetases co
based on JTT matrix model. SYD_ECO45:B7MBS5; SYD_PYRAB:Q9V036; SY
SYD_METAC:Q8TQ68; SYD_METBF:Q466Y5; SYD_METBU:Q12XU7; SYD_HELP
Q559M9; SYDC_BOVIN:Q3SYZ4; SYDC_CAEEL:Q03577; SYDC_RAT:P15178; SY
SYDM_RAT:Q3KRD0; SYDM_SCHPO:O94242; SYDM_YEAST:P15179; SYD_AQ
P47282; SYD_MYCS2:A0QWN3; SYD_MYCTU:Q50649; SYD_PSEAE:Q51422; Sindirect pathway, in addition to a non-discriminating
type AspRS requires GatCAB complex which is a
multiprotein complex involved in transamidation of
AsptRNAAsn. However, L. major has only GatA
(LmjF.16.1360) and a very distant homolog of GatC
(LmjF.18.0110). This distant homolog of GatC in L.
major is closely related to GatF of yeast [46]. Yet GatB is
absent. In P. falciparum only GatA and GatB subunits
have been reported [11]. While, the indirect pathway of
tRNA(Gln) and tRNA(Asn) charging requires either an
GatCAB or GatDE in bacteria and archaea respectively.
It has been reported earlier that yeast requires a GatFAB
for transamidation [46,47]. The GatF subunit belongs to
DUF726 (Domain of unidentified function) family of
PFAM. Our database searches showed that P. falciparum
also has a homolog of GatF (PFL0295c). It is possible that
Leishmania and Plasmodium have a GatFAB instead of
GatCAB. However, this requires validation.
There are two cytosolic ProRS enzymes both of which
are annotated as bifunctional enzymes from L. major
(LmjF.18.1210; LmjF.18.1220). Conserved Domains Data-
base (CDD) based domain assignments suggest that they
have a YbaK domain in addition to the catalytic core and
anticodon binding domains (Table 1). YbaK domain has
been suggested to hydrolyse misacylated tRNAPro; essen-
tially editing function [40]. Sequence based phylogeny of
ProRS from all domains of life suggest that the LmProRS
cluster with other cytosolic eukaryotic and archaeal ProRS
all of which belong to the ProS type 3 subfamily domain
architecture (according to PFAM domain assignment);
while the bacteria and other eukaryotic mitochondrial
enzymes have a ProS type 1 subfamily domain architec-
ture (Figure 4). ProRS have been shown to be capable
of aminoacylating both tRNAPro and tRNACys with theirnstructed using MEGA v5.0 using Maximum Likelihood method
DC_HUMAN:P14868; SYDM_HUMAN:Q6PI48; SYD_META3:A6USZ9;
2:B6JLK1; SYD_METJA:Q58950; SYDC1_DICDI:Q75JQ1; SYDC2_DICDI:
DC_SCHPO:O74407; SYDC_YEAST:P04802; SYDM_DICDI:Q55C99;
UAE:O67589; SYD_BACSU:O32038; SYD_HAEIG:A5UGD3; SYD_MYCGE:
YD2_THETH:333967100; SYD1_THETH:333966377.
Figure 4 Sequence based phylogeny of prolyl tRNA synthetases constructed using MEGA v5.0 using Maximum Likelihood method
based on JTT matrix model. SYPC_CANAL:P78600; SYPC_AQUAE:O66690; SYPC_BACSU:O31755; SYPC_CORDI:Q6NGM7; SYPC_ECO24:A7ZHT6;
SYPC_HAEI8:Q4QMG5; SYPC_LACDA:Q1G9P3; SYPC_META3:A6UTK4; SYPC_MYCPN:P75382; SYPC_MYCS2:A0QVM0; SYPC_MYCTU:O05814;
SYPC_PLAF7:Q8I5R7; SYPM_PSEA7:A6VA16; SYPC_PSEP1:A5VZT5; SYPC_PYRAB:Q9V022; SYPC_PYRFU:Q8U1C4; SYPC_PYRHO:O58734; SYPC_SALTY:
Q7CR62; SYPC_STAA9:A5ISE7; SYPC_SULSO:Q9UWX2; SYPC_VIBCH:Q9KTM7; SYPM_HUMAN:Q7L3T8; SYPM_SCHPO:O74765; SYPM_YEAST:P39965;
SYPC_THET2:Q72GF9; SYPC_YEAST:gi|500692; SYPC_METJA:gi|2501043; SYPC_GIAIN:gi|10800405; SYPC_CAEEL:gi|459009; SYPM_CAEEL:gi|3880329;
SYPC_SCHPO:gi|3218410; SYPC_THEMA:gi|4981026.
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Sequence based clustering of LmProRS with the bifunc-
tional archaeal ProRS enzymes suggest that the bifunc-
tional LmProRS enzymes are probably capable of charging
both tRNAPro and tRNACys with their respective aminoa-
cids. The presence of a ProX type cis editing domain at
the N-terminus of both Leishmania ProRS which specific-
ally hydrolyses the misacylated tRNAPro with Alanine
(Additional file 5: Figure S3) further confirms the bifunc-
tional ability of LmProRS proteins.
Asparagine synthetase A from L. major – A novel enzyme
specific to Prokaryotes and Archaea
Aminoacyl tRNA synthetase paralogs so far have been
reported from prokaryotes [48]. These paralogs while
retaining the aaRS catalytic domain with the characteris-
tic motifs, are primarily involved in aminoacid biosyn-
thesis [49,50]. Examples include AsnA, HisZ, lysylation
of a specifc lysine in EF-P (Genx/PoxA) [49-54] etc. Ab-
sence of these paralogs in mammals makes them unique
antibacterial drug targets. Biochemical characterization
of AsnA and GenX/PoxA from E. coli are available
[51-55]. One of the L. major protein (LmjF.26.0830) hasa AsnRS catalytic core with all the three characteristic
class II motifs conserved (Figure 4b). But, it lacks the
anticodon binding domain essential for tRNA binding
(Table 1). A blast sequence search against PDB database
suggests close sequence similarity (~58%) with E. coli
AsnA. Crystal structure of the E. coli protein indeed
shows a class II tRNA synthetase core domain structure
[55]. The structure based sequence comparison of yeast
AspRS catalytic core with EcAsnA shows conservation of
structurally and catalytically important residues between
the two sequences [55]. While the two substrates
(mgATP and aspartic acid) of these two sequences are
similar, the reactive carboxyl groups of aspartic acid are
different. While in AspRS, the α-carboxyl group of
aspartic acid is activated by ATP, β-carboxyl group is
activated in AsnA (Figure 5a). In prokaryotes, aspara-
gine is formed by two structurally distinct asparagine
synthetases. One is the ammonia utilizing asparagine
synthetase referred as AsnA and the other is the glu-
tamine utilizing asparagine synthetase referred as AsnB.
Although, AsnB can utilize glutamine or ammonia as
the amide donor, glutamine is preferred over ammonia
[56,57]. Recently, the crystal structure of AsnA from an
Figure 5 (See legend on next page.)
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Figure 5 (a) Schematic representation of the difference in the activation of L-Aspartic acid by aspartyl-tRNA synthetase (AspRS) and
Asparagine synthetase A (AsnA). (b) Lysyl tRNA synthetase rooted sequence based phylogeny of Asparagine synthetase A with aspartyl and
asparagine tRNA synthetases. This tree is constructed using MEGA v5.0 using maximum likelihood method based on JTT matrix model.
(c) Structure dependent sequence based phylogeny of the crystal structures of AsnA from E. coli (EcAsnA: 11AS); P. abyssi (PaAsnA: 3P8Y), AspRS
from T. kodakarensis (TkAspRS: 3NEM); T. thermophilus (TtAspRS: 1EFW); T. thermophilus (TtAspRS2: 1IL2); S. cerevisiae (ScAspRSf: 1E0V) and AsnRS
from E. histolytica (EhAsnRS: 3M4P); B. malayi (BmAsnRS: 2XGT). The tree is constructed using the structure based sequence alignment generated
using MUSTANG structural alignment program. (d) A snapshot of the active site residues in EcASA (PDB: 11AS A chain; Red color) with LmASA
structural model (blue color). Structural comparison shows the superposition of the flipping loop and active site residues from both the
structures. The pairwise sequence alignment of the corresponding structural superposition with the respective color coding is also shown. The
ATP binding Glycine residues are shown in BOLD, underlined fonts. The residues in the flipping loop are shown in the yellow boxes and the
active site residues are shown in BOLD font.
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bound forms including AMP, asparatate, asparagine has
guided in decoding the plausible mechanism of aspara-
gine synthesis by the archaeal AsnA enzyme [58,59].
AsnA genes have been reported from prokaryotes and
archaea [59,60], while AsnB genes are reported from all
three domains of life. Leishmania and trypanosoma al-
beit being eukaryotes surprisingly possess AsnA
(LmjF.26.0830) and AsnB (LmjF.29.1490). Swissprot data
[18,19] suggests the presence of AsnA in almost 368
organisms all belonging to prokaryotic origin. In
addition to kinetoplastids, blast searches against
EupathDB database [61] suggest parasites such as
Trichomonas vaginalis (TVAG_340510; E-value: 8.9E-
50); Entamoeba histolytica (EHI_148470; E-value: 1.4E-
73); Cryptosporodium hominis (Chro.50501; E-value:
6.0E-26); Cryptosporodium parvum (cgd5_4540; E-value:
2.1E-52) possess a copy of AsnA gene. LmAsnA is pre-
dicted to be a mitochondrial copy (Table 1). Among the
Class II synthetases, lysine, asparagine and aspartic acid
are closely related in their structure and belong to the
same subtype (Class 2b) [62]. However, evidences sup-
port the evolutionary link between the asparagine
synthetase and aspartyl tRNA synthetases as they both
recognize aspartic acid and ATP [55]. Thus, a LysRS
rooted sequence based phylogeny of AsnA along with
AspRS and AsnRS catalytic core from all three domains
of life clearly shows that the kinetoplastid and other
eukaryotic pathogen AsnA enzymes are of bacterial ori-
gin (Figure 5b) while the archaeal AsnA is derived from
gene duplication events from the ancestral AspRS as
previously mentioned by Blaise and workers [59]. Struc-
ture dependent sequence based phylogeny of all the
available crystal structures of AspRS, AsnRS with the
EcAsnA and PaAsnA enzymes show a similar tree branch-
ing with the EcAsnA structurally closer to the bacterial
AspRS (Figure 5c). The distinct branching of yeast AspRS
free form clearly reflects the conformational rearrange-
ments upon tRNA binding to the yeast AspRS [63].
To date crystal structures of three AsnA enzymes
(from E. coli, P.abyssi and an AsnA peptide structurefrom P. furious) are available. Among the three, amino
acid sequences of L. major AsnA and EcAsnA closer to
each other. Hence, a structural model of LmAsnA was
built using EcAsnA (PDB:11AS) as the template using
Modeller v 9.0. The model was energy minimized using
Amber96 forcefield in gromacs. The quality of the energy
minimized model is then verified using PROCHECK
available at PDBSUM [64] webserver. Structural compari-
son of the LmAsnA model with the E. coli and P.abyssi
homologue suggests that the LmAsnA shares 58%
sequence identity with the bacterial homologue and 19%
sequence identity with the archaeal homologue. The
L. major model superposes with the E. coli and P. abyssi
structures at 0.5Å and 2.9Å RMSD values respectively.
3-D structural comparison of the LmAsnA model with
the EcAsnA (PDB:11AS) shows a complete conservation
of catalytic residues, ATP binding Glycine rich region
and identical flipping loop lengths that covers the active
site at the sequence level and in 3-Dimension (Figure 5d).
Based on the sequence and structural similarities between
the E. coli and the L. major enzymes, D222-Q118 pair of
LmAsnA can be expected to anchor the beta carboxylate
group of the L-aspartic acid. In yeast AspRS, these resi-
dues are substituted by a threonine and a glycine respect-
ively and an Asp342 and Q303 which are at structurally
different positions anchors the beta carboxylate group of
the substrate [55]. While in LmAsnA, EcAsnA and yeast
AspRS, an Asp-Gln pair anchors the beta carboxylate
group of L-aspartic acid, in archaeal AsnA and AspRS
homologues; Aspartic acid is anchored by two arginines
[55]. This suggests that the altered substrate specificity
and the reaction chemistry between the AspRS and AsnA
have been achieved by a few residue substitutions at the
active site. The basic difference in the substrate anchoring
residues between the archaeal and bacterial/kinetoplastid
AsnA enzymes suggests a distinct evolutionary origin be-
tween the archaeal and bacterial/kinetoplastid AsnA.
These key differences between the archaeal and the kine-
toplastid AsnA substrate recognition modes and the
absence of AsnA in human make the kinetoplastid en-
zyme unique drug target for antiparasitic drug design.
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Aminoacyl tRNA synthetases are ubiquitous enzymes
essential for cell viability. Hence, they have been one of
the promising drug targets in antimicrobial infections.
Due to increasing resistance to currently available anti-
leishmanial drugs, aminoacyl tRNA synthetases have
received attention among the kinetoplastid research
community in the recent times. In this study, aminoacyl
tRNA synthetases and their associated proteins from
L. major have been explored for their novel domain
architectures and sequence features. Based on the
domain architecture, we identified 26 indisputable ami-
noacyl tRNA synthetases from L. major, with a predom-
inant predicted localisation of them in the cell cytosol.
Sequence based phylogeny of some specific tRNA synthe-
tases (AspRS and ProRS) confirm their close evolutionary
relationship with archaeal/eukaryotic tRNA synthetases.
In addition to the appended editing domains and N- or
C-terminal extensions which provide additional tRNA
binding, we also identified free standing editing domains
of AlaRS/ThrRS, two ProRS deacylases and two D-
tyrosine deacylases (DTD). Two novel EMAP II-like
sequences containing a heptapeptide motif similar to
the human EMAP II-like sequences were also identi-
fied. The presence of such EMAP II-like sequences sug-
gests the formation of a probable multisynthetase protein
complex as seen in the case of human or their probable
role in trans-activation of certain aminoacyl tRNA synthe-
tases. Presence of ‘ELR’ motif in Lys, Asn, Cys and Tyr
tRNA synthetases provides clues for their participation
in angiogenesis likely. We also highlight the sequence
analysis and 3-D structural modelling of a unique en-
zyme that is completely absent in human, Asparagine
synthetase A from L. major for the first time. While the
aminoacyl tRNA synthetases of L. major show archaeal/
eukaryotic origin, Asparagine synthetase A of L. major
shows bacterial origin. The different substrate recogni-
tion modes of the baterial and archaeal enzymes makes
them unique and worth exploring.Methods
Leishmania major (Version 3.1) from TritrypDB data-
base [65] is used here. Hidden Markov Models (HMM)
[66] were generated using aminoacyl tRNA synthetase
sequences and the editing domain sequences (Ybak,
DTDA, AlaX) from Swissprot database Release 4.0, 2011
[67,68] for each of the 21 tRNA synthetases (20 standard
tRNA synthetases + o -phosphoseryl tRNA(sec) selenium
transferase) and the deacylases of ProRS (YbaK), AlaRS
(AlaX) and D-tyrosine deacylase (DTDA). The distribu-
tion of aaRS sequences from the individual domains of
life used for the generation of HMMs is given in the
Additional file 7: Table S3. hmmbuild and hmmsearchoptions in the suite of HMMER 3.0 package [66] was
used for generation and searches using the HMMs re-
spectively. Multiple sequence alignment used for model
generation was done using MAFFT multiple sequence
alignment tool [69] which employs fast fourier trans-
forms (FFT) for rapid identification of homologous
regions. The accuracy of alignments generated by
MAFFT has been proved comparable to CLUSTALW
and T-coffee progressive alignment methods with the
rapid reduction of CPU time [69]. BLAST Webserver at
NCBI was used extensively for sequence searches against
PDB database [70]. PSORT II [71] was used for subcellu-
lar localization prediction analysis. The prediction ac-
curacy for cross validation of yeast sequences is about
57%. PSORT II does not account for multiple
localization of protein sequences. PSIPRED (Protein
structure prediction server) [72] is used for secondary
structural prediction of the leucyl tRNA synthetase of L.
major. PFAM database [73] from the Sanger Institute,
Conserved Domains Database (CDD Server) at NCBI
[74] and SUPERFAMILY database (Version 1.75) [75]
were used for domain assignments. BLAST searches
against PDB database was used for the assignment of dea-
cylase (Connective peptide; CP) domains for Leu, Ile and
Val tRNA synthetases.Phylogenetic analysis
Phylogenetic analysis of the LmaaRSs was performed com-
bining the set of sequences from the Swissprot/UniprotKB
database [67]. Multiple sequence alignment (MSA) of these
sequences is generated using CLUSTALW with default para-
meters [76]. These MSAs were used as seed sequences for
phylogenetic tree generation using Jones-Taylor-Thornton
(JTT) model [77]. MEGA v5 [78] was used for both analysis
and visualization of the phylogenetic trees.Model building and validation
Comparative structural model of L. major Asparagine
Synthetase A was built using Modeller v9 [79]. Stereochem-
ical quality of the model was verified using PROCHECK in
PDBSUM web resource at EBI [63]. Structural mapping of
the active site residues was performed using Pymol [80].Additional files
Additional file 1: Table S1. Alternative splicing of aaRSs, aaRS paralogs,
editing domains and other associated proteins in Promastigote stages in
Leishmania major.
Additional file 2: Table S2. Distribution of aaRSs, aaRS paralogs,
editing domains and other associated proteins in Leishmania and
Trypanosoma. Organisms are Lm: L. major; Lbr: L. braziliensis; Lta:
L. tarentolae; Lmx: L. mexicana; Lin: L. infantum; Tb427: T.brucei brucei427;
Tb927: T. brucei brucei (TREU927); Tbg: T. brucei gambiense; TcEs: T.cruzi
Esmeraldo; TcNEs: T. cruzi Non-Esmeraldo; Tcon: T. congolense; Tv: T. vivax.
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http://www.biomedcentral.com/1471-2164/13/621Additional file 3: Figure S1. Secondary structure prediction of
LmLeuRS showing the first 300 residues which includes the CP1 domain.
The 35 residue N-terminal insertion in the CP1 domain is highlighted in
yellow. The numerical values corresponds to the confidence levels
(ranging from 0–9). H refers to Helix; C refers to Coil and E refers to
Sheet.
Additional file 4: Figure S2. Sequence based phylogeny of tRNA_SAD
domains (cis/trans) of alanyl tRNA synthetases constructed using MEGA
v5.0 using Maximum Likelihood method based on JTT matrix model.
Bootstrap values are indicated at the inner nodes.
Additional file 5: Figure S3. Sequence based phylogeny of prolyl
tRNA synthetase editing domains (Ybak/ProX) constructed using MEGA
v5.0 using Maximum Likelihood method based on JTT matrix model.
Bootstrap values indicated at the inner nodes indicate the similarity of
tethered editing domains of LmProRS to AlatRNAPro type editing domains
(ProX) and the standalone editing domains of LmProRS to CystRNAPro
type (Ybak).
Additional file 6: Figure S4. Sequence based phylogeny of D-tyrosine
deacylases (Dtdas) from DTDA2_HUMAN (sp|Q96FN9); DTD2_MOUSE (sp|
Q8BHA3); DTD2_DANRE (sp|Q68EL2); DTD1_ECOLI (1JKE); DTD2_HINF
(1J7G); DTD1_AAQU (2DBO); DTD1_PFAL (3K05); DTD1_BOVIN (sp|
Q2T9V8); DTD1_HUMAN (2OKV);GEK1_ARATH (sp|Q9ZPQ3); DTDA_PYRFU
(sp|P58852); DTDA_PYRHO (sp|O57774); DTDA_PYRAB (sp|Q9V2R8)
constructed using MEGA v5.0 using Maximum Likelihood method based
on JTT matrix model. Bootstrap values are indicated at the nodes.
Additional file 7: Table S3. Distribution of aaRS sequences used for
generation of HMMs for all the 21 aaRS from the Swissprot database in
Bacteria, Archea, Eukaryotes and Virus is given in the table.
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